PRENETICS GLOBAL LTD-CL A
PRENASDAQTrading Snapshot
- Day Range
- $22.67 – $23.19
- 52-Week Range
- $11.37 – $27.24
- Volume
- $4.34B
- Avg Volume
- $3.57B
- Shares Outstanding
- 17.0M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $92M
- Last Q Revenue
- $46M
- P/E Ratio
- -5.5
- P/S Ratio
- 2.7x
- EPS (TTM)
- $-3.92
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +26.2%
Why Investors Own PRE
- ✓High-growth profile — revenue up +4.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 37% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PRENETICS GLOBAL LTD-CL A
PRE
StockOtter · stockotter.spaceAbout PRENETICS GLOBAL LTD-CL A
As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
U.S. VEHICLE SALES UNLIKELY TO REGAIN PRE-PANDEMIC LEVELS THIS DECADE, MOBILITY GLOBAL FORECAST SHOWS
DETROIT, Sept. 28, 2026 /PRNewswire/ -- According to Mobility Global's latest forecast, U.S. light-vehicle sales are expected to reach 16.1 million units in 2026 and only 16.4 million by the end of the decade, remaining
Prenetics Global Limited (NASDAQ:PRE) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Prenetics Global Limited (NASDAQ: PRE - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the firm, Marketbeat reports. One analyst h
Prenetics' IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
Cumulative Personal Investment by Leadership Since November 2025 Reaches Approximately $3.75 Million NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a le
Prenetics Global: Marketing Mastery The Key To Robust Revenue Growth
Prenetics Global Limited has achieved explosive growth, reaching 140,000 subscriptions in 20 months, driven by its IM8 supplement and AI-powered marketing. One of the keys to this growth is its marketing mastery, using A
Prenetics Global Limited (PRE) Q2 2026 Earnings Call Transcript
Prenetics Global Limited (PRE) Q2 2026 Earnings Call Transcript
Prenetics' IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
— Lily is IM8's first Global Ambassador from film and television, extending a roster built in elite sport into global entertainment and culture — Lily brings a following of more than 33 million across social platforms an